Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit (PICU) at KASCH-MNGHA.

NCT05485519 is registered in ClinicalTrials.gov with King Abdullah International Medical Research Center as lead sponsor.

NCT NCT05485519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05485519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit (PICU) at KASCH-MNGHA.
Lead sponsor
King Abdullah International Medical Research Center
Phase
Phase 3
Overall status
Unknown status
Start date
April 21, 2022
Completion date
May 31, 2024
Enrollment
430 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, failure of extubation, midazolam, withdrawal symptoms